2023-10-01 12203537 2024-09-30 12203537 2023-10-01 2024-09-30 12203537 2023-09-30 12203537 2022-10-01 2023-09-30 12203537 uk-core:WithinOneYear 2023-09-30 12203537 uk-core:WithinOneYear 2024-09-30 12203537 uk-bus:Director1 2023-10-01 2024-09-30 iso4217:GBP xbrli:pure 12203537 uk-bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 12203537 uk-bus:Micro-entities 2023-10-01 2024-09-30 12203537 uk-bus:FullAccounts 2023-10-01 2024-09-30 12203537 uk-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30
Draft
Targeted Medical Writing Solutions Limited
Registered Number:12203537
For the year ended 30 September 2024
England and Wales
Unaudited Financial Statements
2
Draft
For the year ended 30 September 2024
Targeted Medical Writing Solutions Limited
Contents Page
1 to 2
Statement of Financial Position and Notes to the
Accounts
3
Draft
12203537
Registered Number :
As at 30 September 2024
Targeted Medical Writing Solutions Limited
Statement of Financial Position and Notes to the Accounts
£
£
2023
2024
£
£
23,110
27,556
Fixed assets
346,496
237,131
Current assets
Creditors: amounts falling due
within one year
(34,577)
(54,130)
202,554
292,366
Net current assets
Total assets less current liabilitie
s
315,476
230,110
315,476
Net assets
230,110
315,476
230,110
Capital and reserves
Notes to the Accounts
Statutory Information
Targeted Medical Writing Solutions Limited is a private limited company, limited by shares, domiciled in
England and Wales, registration number 12203537.
Registered address:
29 Bath Road
Peasedown St John
Bath
BA2 8DJ
The presentation currency is £ sterling.
1. Average number of persons employed
During the year the average number of employees was 1 (2023 : 1)
1 of 2
4
Draft
12203537
Registered Number :
For the year ended 30 September 2024
Targeted Medical Writing Solutions Limited
Statement of Financial Position and Notes to the Accounts Continued
For the year ended 30 September 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company
as at the end of each financial year and of its profit or loss for each financial year in accordance with
the requirements of Section 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.
These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies
Mr R J Eagling-Vose Director
These financial statements were approved and authorised for issue by the Board on 23 October 2024 and were signed by:
2 of 2